Madushini Dharmasena

FDA investigator

Appears on 13 documents from 2019 to 2025, most often at sites in India. Most often cites control of microbiological contamination (21 CFR 211.113).

13
Documents on file
5.5
Observations per 483
2019
First seen
2025
Most recent

What they cite most

From 71 observations

Activity by year

2019: 3, 2021: 2, 2022: 2, 2023: 3, 2024: 1, 2025: 2

Where

India 3 · South Korea 2 · Australia 1 · Germany 1 · Iceland 1 · Ireland 1

Is Madushini Dharmasena coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

13 documents, newest first
FirmOpen
483 Dr. Reddy's Laboratories, LTD, BiologiesSep 12, 2025 · Telangana, India
483 Sanofi-Aventis Deutschland GmbHJan 16, 2025 · Frankfurt am Main, Germany
483 CSL Behring (Australia) Pty LtdMar 8, 2024 · Broadmeadows, Australia
483 DR.REDDY'S LABORATORIES LIMITEDOct 12, 2023 · Bachupally Village, India
483 Dr. Reddy's Laboratories, Ltd.Oct 12, 2023 · Hyderabad, India
483 PharmaEssentia Corporation, Taichung PlantSep 21, 2023 · Taichung, Taiwan
483 Samsung Biologics Co., Ltd.Jun 9, 2022 · Incheon, South Korea

About this profile

What does Madushini Dharmasena inspect?

Madushini Dharmasena appears on 13 documents on file covering 10 sites, most often in India.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.192 and 21 CFR 211.100.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Madushini Dharmasena is dated Sep 12, 2025.

FDA Investigator Madushini Dharmasena: 483s & Inspections · FDA Intel